Yoshitatsu Fukabori
Papers
1
Total Citations
12
H-Index
1
About
Dr. Yoshitatsu Fukabori is a urologic oncologist whose research focuses on improving risk stratification and surgical outcomes for prostate cancer patients. His work centers on refining predictive models using prostate-specific antigen (PSA) density and detailed biopsy core characteristics to guide treatment decisions, particularly for intermediate to high-risk disease. In his most cited study (2017, 12 citations), Fukabori demonstrated how integrating PSA density with biopsy core details can better predict oncological outcomes following robot-assisted radical prostatectomy. This contribution helps urologic surgeons determine the need for extended resection or lymph node dissection, ultimately personalizing surgical approaches. His research addresses a critical gap in localized prostate cancer management, where precise risk assessment is essential for balancing cancer control with quality of life. By advancing evidence-based criteria for surgical planning, Fukabori’s work supports more tailored interventions for patients with aggressive disease. His ongoing investigations continue to refine these predictive tools, aiming to improve long-term outcomes and reduce overtreatment in prostate cancer care.
Research Focus
Key Achievements
Top Papers
- 1